Journal
BLOOD
Volume 139, Issue 8, Pages 1126-1128Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2021013771
Keywords
-
Categories
Ask authors/readers for more resources
In their study, Yang et al found that 13.6% of AML patients unselected by family history have pathogenic or likely pathogenic variants of known cancer-predisposition genes.
In this issue of Blood, Yang et al(1) report on the germline screening of 391 patients from the BEAT acute myeloid leukemia (AML) study, finding that 13.6% of patients unselected by family history have pathogenic or likely pathogenic variants of known cancer-predisposition genes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available